The U.S. Food and Drug Administration has approved the first new weight loss drug in more than a decade.
Arena Pharmaceutical's anti-obesity pill Belviq was cleared for use by adults who are overweight and have at least one medical complication like diabetes or high cholesterol.
The FDA initially rejected the drug in 2010 after animals developed tumors during testing.
The agency reconsidered after the company submitted additional data this year.
Doctors have been urging the FDA to approve new weight loss treatments to combat the nation's growing obesity problem.